Investor Presentaiton

Immunology LPA₁ Sotyktu CD19 NEX T Rapidly expanding into other B-cell mediated diseases ጸ Numerous B-cell mediated diseases with select patient populations SLE Systemic Sclerosis Idiopathic inflammatory Multiple Myopathies Sclerosis Other indications Adding cohorts to Phase 1 severe, refractory SLE trial (e.g., myositis and others) Phase 1 trial in Multiple Sclerosis to be initiated Ill Bristol Myers Squibb™ Not for Product Promotional Use 71

View entire presentation